TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/11/21 17:36 | 3/9/21 | WIZP | Wize Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Danenberg Noam | L3 | DO | CEO | P | 350 | 0.1200 | 0 | 2,917 | 999% | 3,166 | D | ||||||||||||||
12/31/20 17:24 | 12/29/20 | WIZP | Wize Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Danenberg Noam | L3 | DO | CEO | S.d | 0 | 0.00 | 0 | -15 | 0 | 3,881 | M | ||||||||||||||
9/16/19 17:16 | 6/30/19 | WIZP | Wize Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Danenberg Noam | L3 | O | CEO | M.d | 0 | 0.00 | 0 | 18 | 14 | 143 | D | ||||||||||||||
4/23/19 18:00 | 4/21/19 | WIZP | Wize Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Danenberg Noam | L3 | O | CEO | P.d | 125 | 1.00 | 0 | 125 | 312 | 165 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |